Not applicableActive Not RecruitingNCT05196269What this trial is testingComparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.Who this might be right forBreast Cancer Fundacao Champalimaud 1,030
Not applicableWithdrawnNCT01326468What this trial is testingTorisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450What this trial is testingDupilumab_Metastatic NSCLCWho this might be right forMetastatic Non-small Cell Lung Cancer Thomas Marron 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06494150What this trial is testingNab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)Who this might be right forLow Grade Ovarian Serous Adenocarcinoma University of Oklahoma 37
Testing effectiveness (Phase 2)Study completedNCT00777491What this trial is testingChemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by SurgeryWho this might be right forBladder Cancer Radiation Therapy Oncology Group 70
Testing effectiveness (Phase 2)WithdrawnNCT00227474What this trial is testingS0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in RemissionWho this might be right forBreast Cancer SWOG Cancer Research Network
Not applicableLooking for participantsNCT06371274What this trial is testingA Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.Who this might be right forTriple-negative Breast Cancer First Affiliated Hospital of Zhejiang University 29
Early research (Phase 1)Looking for participantsNCT07586618What this trial is testingFirst-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.Who this might be right forLymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL Allterum Therapeutics, Inc 24
Early research (Phase 1)Active Not RecruitingNCT06125197What this trial is testingOncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung CancerWho this might be right forLung Cancer TILT Biotherapeutics Ltd. 22
Not applicableLooking for participantsNCT07234110What this trial is testingCD5 CART for the Treatment of Relapsed and Refractory CD5 Hematological TumorsWho this might be right forRelapsed and Refractory CD5 Hematological Tumors Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Study completedNCT00390182What this trial is testingLow Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)Who this might be right forGastrointestinal NeoplasmsOvarian Neoplasms University of Maryland, Baltimore 38
Large-scale testing (Phase 3)WithdrawnNCT03536182What this trial is testingTrial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Adenocarcinoma University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05789082What this trial is testingA Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824What this trial is testingStudy of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesWho this might be right forBreast CancerBrain Metastases, Adult Colette Shen 41
Early research (Phase 1)Study completedNCT00516724What this trial is testingStudy to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelWho this might be right forTriple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more AstraZeneca 189
Testing effectiveness (Phase 2)Ended earlyNCT02842580What this trial is testingDe-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Federation Francophone de Cancerologie Digestive 21
Testing effectiveness (Phase 2)UnknownNCT04935580What this trial is testingStudy of FasT CAR-T GC012F Injection in High Risk TE NDMM PatientsWho this might be right forMultiple Myeloma Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04835896What this trial is testingStudy of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric CancerWho this might be right forRecurrent/Metastatic Gastric Cancer Yonsei University 49
Not applicableLooking for participantsNCT07316062What this trial is testingA Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in ChinaWho this might be right forNon-Small-Cell Lung AstraZeneca 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT01081262What this trial is testingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerWho this might be right forBorderline Ovarian Mucinous TumorOvarian Mucinous CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+21 more National Cancer Institute (NCI) 50